I-Tech AB ITECH.ST
ITECH.ST
I-Tech AB ONCO.ST
Oncopeptides AB (publ) SYNACT.ST
SynAct Pharma AB XSPRAY.ST
Xspray Pharma AB (publ) GENO.ST
Genovis AB (publ.) CRAD-B.ST
C-Rad AB (publ) IBT-B.ST
Infant Bacterial Therapeutics AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) CANTA.ST
Cantargia AB (publ) SEDANA.ST
Sedana Medical AB (publ)
I-Tech AB ONCO.ST
Oncopeptides AB (publ) SYNACT.ST
SynAct Pharma AB XSPRAY.ST
Xspray Pharma AB (publ) GENO.ST
Genovis AB (publ.) CRAD-B.ST
C-Rad AB (publ) IBT-B.ST
Infant Bacterial Therapeutics AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) CANTA.ST
Cantargia AB (publ) SEDANA.ST
Sedana Medical AB (publ)
Performance
| Periode | ITECH.ST | ONCO.ST | SYNACT.ST | XSPRAY.ST | GENO.ST | CRAD-B.ST | IBT-B.ST | DMYD-B.ST | CANTA.ST | SEDANA.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -6.77 % | 157.87 % | 17.97 % | -26.99 % | 10.20 % | 12.69 % | 26.97 % | 42.29 % | 55.10 % | 51.44 % |
| YTD | 24.00 % | 221.52 % | 133.16 % | -39.43 % | -9.22 % | 12.50 % | 6.62 % | -36.69 % | 43.24 % | -30.92 % |
| 1Y | 50.00 % | 143.06 % | 152.61 % | -56.50 % | -3.49 % | -9.51 % | 74.36 % | -18.18 % | -18.83 % | -44.37 % |
| 3Y | 65.70 % | -40.86 % | -56.30 % | -55.36 % | -39.97 % | -4.03 % | 7.94 % | -17.68 % | -35.07 % | -50.70 % |
| 5Y | 4.20 % | -95.65 % | -53.12 % | -81.10 % | -30.46 % | -8.64 % | -58.98 % | -68.65 % | -95.56 % | -81.16 % |
| 10Y | 201.58 % | -83.42 % | 336.78 % | -15.13 % | 1 167.73 % | 79.37 % | 4.68 % | 73.18 % | -67.13 % | 111.76 % |
| Depuis le début | 201.58 % | -83.42 % | 336.78 % | -15.13 % | -54.74 % | 133.77 % | 4.68 % | 228.87 % | -71.33 % | 111.76 % |